Mera-med | .ru |
|
медицинское оборудование онкологияGood-quality tumours - tumor benignum, grow slowly, can exist years, not increasing. They are surrounded with own environment. At growth, increasing, the tumour removes surrounding fabrics, not destroying them. The histologic structure of a tumour insignificantly differs from a fabric in which she{it} developed. Therefore good-quality tumours carry names of own fabrics from which they have developed, with addition of a suffix of "ohm" from the Greek term "онкома" (tumour). For example, a tumour from fatty weaved - липома, from connecting - a fibroma, from muscular - a myoma, from a bone fabric - остеома, etc. Removal{Distance} of a good-quality tumour with its{her} environment conducts to full treatment of the patient. Подробнее... The sizes of tumoral formations{educations} after циторедуктивной operations essentially influence results of the subsequent therapy and the forecast of the patient. So, average life expectancy of patients with the sizes of residual tumoral units less than 0,5 sm make 40 months, and at the sizes of 18 and 6 months of 0,5-2 and more 2 sm accordingly [2]. For this reason optimum executed циторедуктивной operation considers at what the maximal sizes of the staying tumoral formations{educations} do not exceed 2 see. In some centers under optimum циторедукцией accept the sizes of the staying tumoral formations{educations} less than 1 see. For achievement similar циторедукции the surgeon sometimes should carry out plural resections of a gut, a liver, a spleen, a bladder, a diaphragm, to use ultrasonic аспиратор and laser коагулятор for removal{distance} fine диссеминатов. Clearly, that циторедуктивные operations are considered technically complex{difficult} and demand high qualification of the surgeon specializing in онкогинекологии. Despite of all this, frequency of performance optimum циторедукции in conducting{leading} clinics of the world makes 23-54 %, and only separate authors achieve it at 75-90 % of patients. Подробнее...
Смотри также:медицинские учреждения москва онкология противорвотная терапия в онкологии метастазы рака молочной железы |